A Bioequivalence Study Of AG-013736 Tablets Under Fed Conditions In Healthy Volunteers
Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
The purpose is to show that 5 mg Form IV tablet of AG-013736 produces similar drug
concentrations in plasma compared to 5 mg Form XLI tablet of AG-013736 after oral dosing
under fed conditions.